|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$4.43 |
$5.03 |
$4.26 |
$4.70 |
335.10K | 04/19/2024 |
$4.77 |
$4.90 |
$4.62 |
$4.87 |
303.30K | 04/22/2024 |
$4.90 |
$5.51 |
$4.87 |
$5.51 |
530.20K | 04/23/2024 |
$5.49 |
$5.74 |
$5.40 |
$5.60 |
220.90K | 04/24/2024 |
$5.61 |
$5.61 |
$5.24 |
$5.45 |
190.70K |
|
Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan. | |
|
Delcath Systems (DCTH) has the following price history information. Looking back at DCTH historical stock prices for the last five trading days, on April 18, 2024, DCTH opened at $4.43, traded as high as $5.03 and as low as $4.26, and closed at $4.70. Trading volume was a total of 335.10K shares. On April 19, 2024, DCTH opened at $4.77, traded as high as $4.90 and as low as $4.62, and closed at $4.87. Trading volume was a total of 303.30K shares. On April 22, 2024, DCTH opened at $4.90, traded as high as $5.51 and as low as $4.87, and closed at $5.51. Trading volume was a total of 530.20K shares. On April 23, 2024, DCTH opened at $5.49, traded as high as $5.74 and as low as $5.40, and closed at $5.60. Trading volume was a total of 220.90K shares. On April 24, 2024, DCTH opened at $5.61, traded as high as $5.61 and as low as $5.24, and closed at $5.45. Trading volume was a total of 190.70K shares.
DCTH Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Delcath Systems shares, starting with a $10,000 purchase of DCTH, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/03/2018 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$1.35 |
|
End price/share: |
$5.45 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
303.70% |
|
Average Annual Total Return: |
26.28% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$40,370.49 |
|
Years: |
5.98 |
|
|
|
Date |
Close |
04/18/2024 | $4.70 | 04/19/2024 | $4.87 | 04/22/2024 | $5.51 | 04/23/2024 | $5.60 | 04/24/2024 | $5.45 |
|
|